Bioartificial pancreas: Materials, devices, function, and limitations

Diabetes Technology and Therapeutics

Volumn 3, Issue 3, 2001, Pages 431-449

  Prokop, A ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; POLITEF; POLYMER;

ALLOGRAFT; ARTIFICIAL PANCREAS; BIOENGINEERING; CELL DIFFERENTIATION; CELL GROWTH; DEVICE; ENDOCRINE CELL; IMMUNOMODULATION; MEMBRANE PERMEABILITY; MICROENCAPSULATION; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; XENOGRAFT;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; CELLS, CULTURED; HUMANS; PANCREAS; PANCREAS, ARTIFICIAL; PROSTHESIS DESIGN;

EID: 0034754076     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/15209150152607213     Document Type: Review

References (162)

1. Microencapsulated islets as bioartificial endocrine pancreas
2. Semipermeable aqueous microcapsules. Artificial cells. V. Permeability characteristics
3. Xenogeneic cell therapy: Current progress and future developments in porcine cell transplantation
4. A diabetic rabbit model for pig islet xenotransplantation
5. Transgenic pigs and virus adaptation
6. Search for cross-species transmission of porcine endogenous retroviruses in patients treated with living pig tissue
7. A polymerase chain reaction-based protocol for the detection of transmission of pig endogenous retroviruses in pig to human xenotransplantation
8. The potential of porcine islet xenotransplantation in the therapy of diabetes
9. Development of the biphasic response to glucose in fetal and neonatal rat pancreas
10. Large scale isolation, growth, and function of porcine neonatal islet cells
11. Neonatal pig islets induce a lower T-cell response than adult pig islets in IDDM patients
12. Expression of Galα(1,3)Gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis
13. Expression of the GALα(1-3)GAL epitope on pig islets
14. A comparison of fetal and adult porcine islets with regard to Galα(1,3)Gal expression and the role of human immunoglobulins and complement in islet cell cytotoxicity
15. Engineering panreatic islets
16. Tissue engineering of a bioartificial pancreas: Modeling the cell environment and device function
17. Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors
18. Transfection of human pancreatic islets with an antiapoptotic gene (blc-2) protects beta-cells from cytokine-induced destruction
19. Regulated expression of mature insulin in the liver of transgenic mice
20. Glucose-regulated insulin expression in diabetic rats
21. Engineered pituitary cells for encapsulation-based diabetes cell therapy
22. Glucose-dependent insulin release from genetically engineered K cells
23. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia
24. Ductal cyst formation in collagen-embedded adult human islet preparations
25. In vitro cultivation of human islets from expanded ductal tissue
26. Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas
27. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells
28. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters
29. Beta cell proliferation and growth factors
30. Extra-insular beta cells associated with ductules are frequent in adult human pancreas
31. Multipotent nestin-positive stem cells isolated from adult pancreatic islets differentiated ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes
32. Increased islet allograft survival after extended culture by a mechanism other than depletion of donor APCs
33. Long-term survival, morphology and in vitro function of isolated pig islets under different culture conditions
34. Prolongation of islet allograft survival following in vitro culture (24°C) and a single injection of ALS
35. Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets
36. Effects of incubation of islet cells with transforming growth factor beta (TGF-β) on their susceptibility to diabetic lymphocyte-mediated destruction in the rat, in vitro
37. Mechanism of cytokine-mediated localized immunoprotection
38. beta
39. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection agains effector lymphocytes by transgenic paracrine TGF-β1
40. Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide - But not interleukin-1β-induced inhibition of glucose metabolism in rat pancreatic islets
41. Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets
42. Effects of crosslinked hemoglobin on insulin secretion and viability of islets of Langerhans
43. Cotransplantation of allogenic islets with allogenic testicular cell aggregates allows long-term graft survival without systemic immunosuppression
44. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies
45. Chimerism and xenotransplantation. New concepts
46. CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice
47. Biolistic-mediated interleukin 4 gene transfer prevents the onset of type 1 diabetes
48. Islet cryopreservation protocols
49. Comparison of methods used for the removal of DMSO following cryopreservation and the development of an automated protocol
50. Normalization of diabetes by xenotransplantation of cryopreserved microencapsulated pancreatic islets. Application of a new strategy in islet banking
51. Storage and microencapsulation of islets for transplantation
52. Sertoli cell-induced defects on functional and structural characteristics of isolated neonatal porcine islets
53. Objectively assessing bioartificial organs
54. Pancreatic islets
55. Viability analysis of cryopreserved rat pancreatic islets using laser confocal microscopy
56. Cryopreservation of pancreatic islets prior to transplantation: A comparison between UW solution and RPMI culture medium
57. Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas
58. Perifusion of isolated rat islets in vitro. Participation of the microtubular system in the biphasic release of insulin
59. Novel, nonrinophagic, degradation of connecting peptide in transformed pancreatic beta cells
60. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm
61. Essential biochemical design features of the fuel-sensing system in pancreatic β-cells
62. Importance of the hepatic glycose level in generation of the portal signal in conscious dogs
63. New advances in the treatment of diabetes
64. Functional evaluation of isolated human islets of Langerhans with alpha-cell deficiency
65. Artificial concentration glucose sensing and insulin delivery: Implications of peritoneal administration
66. Timing of insulin delivery with meals
67. Glucose-insulin kinetics of the extravascular bioartificial pancreas. A study using microencapsulated rate islets
68. Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas
69. An encapsulation system for the immunoisolation of pancreatic islets
70. Generation of alginate-poly-L-lysine alginate (APA) biomicrocapsules: The relationship between the membrane strength and the reaction conditions
71. Coherent microcapsules for pancreatic islet transplantation: A new approach for bioartificial pancreas
72. Barium-alginate beads for immunoisolated transplantation of islets of Langerhans
73. Causes of destruction of microencapsulated islet grafts: Characteristics of a "double-wall" poly-L-lysine-alginate microcapsule
74. Xenotransplantation of cells using biodegradable microcapsules
75. New membrane for cell transplantation
76. Microencapsulation of islets in PEG-amine modified alginate-poly-(L-lysine)-alginate microcapsules for constructing bioartificial pancreas
77. Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation
78. Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas
79. Treatment of rat pancreatic islets with reactive PEG
80. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes
81. Entrapment of islets into reversible disulfide hydrogels
82. Bioartificial organs I: Silica gel encapsulated islets for the treatment of diabetes mellitus
83. Encapsulation of viable animal cells for hybrid bioartificial organs by the Biosil method
84. In vitro studies on a new method for islet microencapsulation using a thermoreversible gelation polymer, N-isopropylacrylamide-based copolymer
85. Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas
86. Reversal of diabetes in non-obese diabetic mice by xenografts of porcine islets entrapped in hollow fibres composed of polyacrylonitride-sodium methacrylsulphonate copolymer
87. In vitro test of new biomaterials for the development of a bioartificial pancreas
88. Water soluble polymers for immunoisolation I: Complex coacervation and cytotoxicity
89. Induction of cytokine production from human monocytes stimulated with alginate
90. In vitro activation of human macrophages by alginate-polylysine microcapsules
91. Optimization of the microencapsulated islet for transplantation
92. Production of mitogen-containing free alginates with different variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis
93. Purification of polymers used for fabrication of an immunoisolation barrier
94. Production of purified alginates suitable for use in immunoisolated transplantation
95. Technology of mammalian cell encapsulation
96. Cell transplantation for endocrine disorders
97. Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets
98. Making microencapsulation work: Confocal coating, immobilization gels and in vivo performance
99. Membrane immunoisolation of a diffusion chamber for bioartificial pancreas
100. Use of diffusion model for assessing the performance of poly(vinyl) alcohol) bioartificial pancreases
101. Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas
102. Implantation of a bio-artificial insulin distributor in dogs, using islets of Langerhans from different animal species
103. Bioartificial pancreas in autoimmune nonobese diabetic mice
104. Glucose-insulin kinetics of a bioartificial pancreas made of an AN69 hydrogel hollow fiber containing porcine islets and implanted in diabetic mice
105. Use of a diffusion model for assessing the performance of poly(vinyl alcohol) bioartificial pancreases
106. Long survival of xenografted bioartificial pancreas with a mesh-reinforced polyvinyl alcohol hydrogel bag employing a B-cell line (MIN6)
107. U-shaped bioartifical pancreas with rapid glucose-insulin kinetics. In vitro evaluation and kinetic modeling
108. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival
109. Ex vivo evaluation in normal dogs of insulin released by a bioartificial pancreas containing isolated rate islets of Langerhans
110. Membrane bioreactors as hybrid artificial pancreas: Experimental evaluation
111. Isolation of islets from the pig pancreas and their short-term use in an extracorporeal bioartificial pancreas in rats
112. A bioartificial pancreas as a vascular prosthesis
113. Pancreatic islet cell transplant
114. Evaluation of microcapsule permeability via inverse size exclusion chromatography
115. Control and measuremet of permeability for design of microcapsule cell delivery system
116. Permeability assessment of capsules for islet transplantation
117. Mechanical strength of single microcapsules determined by a novel micromanipulation technique
118. Rapid photopolymerization of immunoprotective gels in contact with cells and tissue
119. Chitosan-carboxymethyl cellulose hydrogels as support for cell immobilization
120. Analysis of ultrafiltration and mass transfer in a bioartificial pancreas
121. Theoretical analysis of the effect of convective flow on solute transport and insulin release in a hollow fiber bioartificial pancreas
122. Numerical investigation of a novel spiral wound membrane sandwich design for an implantable bioartificial pancreas
123. Theoretical and experimental analysis of a hybrid bioartificial membrane pancreas: A distributed parameter model taking into account Starling fluxes
124. Analysis of glucose and insulin mass transfer in a novel 2-channel bioartificial pancreas
125. Transport phenomena and kinetics in an extravascular bioartificial pancreas
126. Complement permeability in bio-artificial endocrine pancreas using a diffusion chamber
127. Method for measuring in vivo oxygen transport rates in a bioartificial organ
128. In situ electrochemical oxygen generation with an immunoisolation device
129. Biohybrid artificial pancreas
130. Normalization of pancreatic exocrine enzymes by islet transplantation in diabetic rats
131. Encapsulated islet transplantation: Pathway to human clinical trials
132. Engineering the tissue which encapsulates subcutaneous implants: Plasma-tissue exchange properties
133. Transplantation of microencapsulated islets in rats: Evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules
134. Xenogeneic humoral responses to islets transplanted in biohybrid diffusion chambers
135. Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)lysine-alginate (APA) membrane following allogenic transplantation
136. Immunoisolation of pancreatic B cells by microencapsulation. An in vitro study
137. Biomedical polymers differ in their capacity to activate complement
138. The effects of porosity on endothelialization of ePTFE implanted in subcutaneous and adipose tissue
139. Angiogenesis in cultured and cryopreserved pancreatic islet grafts
140. Time course of membrane microarchitecture-driven neovascularization
141. Porcine islet xenotransplantation utilizing a vascularized bioartificial pancreas
142. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor
143. Neovascularization of synthetic membranes directed by membrane microarchitecture
144. Biological molecule-impregnated polyester: An in vitro angiogenesis study
145. Repair and regenerative responses
146. VEGF deprivation-induced apoptosis is a component of programmed capillary regression
147. Towards retrievable vascularized bioartificial pancreas (VBAP): Induction and long-lasting stability of polymeric mesh implant vascularized with help of fibroblast growth factors a and b and hydrogel coating
148. Long-term neovascularization and capsule thickness surrounding implants coated with hydrogel matrices
149. Promotion of neovascularization around hollow fiber bioartificial organs using biologically active substances
150. Modification of capsule formation around implants using matrices embedded with growth factors
151. Generation of capillary bed for islet transplantation
152. Development of a new bioartificial pancreas possessing angiogenesis-inducing function
153. Development of artificially vascularized tissue scaffolds for islet transplantation
154. Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells
155. Microencapsulation of pancreatic islet cells: A bioartificial endocrine pancreas
156. Pancreatic islet transplantation - Open issues
157. Towards gene therapy of diabetes mellitus
158. What we have learned from clinical trials regarding the requirement for cell encapsulation